News

09 November 2013

Pharmaceutical expenditure cutbacks pose a great health risk to patients, as stated by leading representatives of the Greek Pharmaceutical sector

An appeal to increase pharmaceutical expenditure in order to ensure the patients's access to reliable and qualitative treatments was made by the leaders of the Pharma sector on Saturday, November 9, at the 1st Greek National Conference on "Crisis Management in the Pharmaceutical Sector".

31 October 2013

ELPEN's strategic global expansion spearheaded by the ground-breaking device: Elpenhaler^{^®}

ELPEN drugs are exported to 60 countries worldwide, 27 of which are in Europe, with the primary aim to achieve further global expansion, spearheaded by Elpenhaler®, an original product, patented by the company's founder, Mr. Dimitrios Pentafragas.